Prostate Cancer Epidemiology and Chemical Exposures
Prostate cancer is the most common cancer in men, with significant geographic variation suggesting environmental influences beyond genetics. Androgen-disrupting chemicals including PFAS are under investigation as prostate carcinogenesis contributors.
Androgen Receptor Modulation by PFAS
PFAS compounds interact with androgen receptors, altering transcriptional activity in prostatic epithelial cells. Both agonistic and antagonistic effects have been documented depending on PFAS chain length and concentration, creating complex dose-response relationships.
Epidemiological Evidence
Studies of PFAS-manufacturing worker cohorts show elevated prostate cancer incidence compared to unexposed workers. Community-level analyses of PFAS-contaminated areas also suggest higher prostate cancer rates, though confounding factors complicate interpretation.
Screening and Early Detection
Men in PFAS-contaminated communities, particularly those over 45, should discuss prostate cancer screening with urologists. PSA testing initiation and frequency decisions may need to account for elevated environmental carcinogen exposures.